RxDoctor Payments Data

Erica Thomason

Family · Evansville, INNPI 1619454188

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $10,915 of the $13,793 with a category attached, or 79.1%. AbbVie accounts for 84.5% of it on its own, with 37 other manufacturers making up the rest. Reporting peaked in 2021 at $11,841 and has fallen 98.9% since, to $132 in 2023. Among family clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$13,793in general payments, 2019–2025

Across 179 payments — averaging $77.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$12K
  • Biohaven Pharmaceuticals, Inc.$290
  • Biogen$260
  • Avanir Pharmaceuticals, Inc.$221
  • Dynasplint Systems Inc.$121
  • UCB, Inc.$71
  • plus $1K from 32 others

What the payments were for

  • Speaking & faculty fees$10,91579%
  • Food & beverage$2,87221%
  • Education$70%

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$13,793 in reported general payments places this provider in the 95th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Other family in Evansville

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →